|
Distribution of select risk factors across categories of aspirin use among 126,124 women, National Institutes of Health–AARP Study |
||||||||
| Frequency of aspirin use in past 12 months |
||||||||
|
|
||||||||
| None |
<weekly |
1–6 times/week |
1+/day |
|||||
|
|
||||||||
| Characteristic |
n |
%a |
n |
%a |
n |
%a |
n |
%a |
|
|
||||||||
| Age at second questionnaire |
||||||||
| <57 years |
8,178 |
19.0 |
8,629 |
21.7 |
4,029 |
20.1 |
2,936 |
13.3 |
| 57–60 years |
8,317 |
19.4 |
8,211 |
20.6 |
4,022 |
20.1 |
3,566 |
16.2 |
| 61–64 years |
9,750 |
22.7 |
9,025 |
22.7 |
4,644 |
23.2 |
5,132 |
23.2 |
| 65–68 years |
11,085 |
25.8 |
9,459 |
23.8 |
4,881 |
24.3 |
6,607 |
29.9 |
| 69+ years |
5,630 |
13.1 |
4,457 |
11.2 |
2,481 |
12.4 |
3,839 |
17.4 |
| Race/ethnicity |
||||||||
| Caucasian/non-Hispanic white |
38,339 |
89.2 |
36,340 |
91.4 |
18,561 |
92.5 |
20,381 |
92.3 |
| Other/unknown |
4,621 |
10.8 |
3,441 |
8.6 |
1,496 |
7.5 |
1,699 |
7.7 |
| Education |
||||||||
| <High school/high school grad |
13,537 |
32.5 |
10,675 |
27.5 |
5,769 |
29.6 |
6,857 |
32.0 |
| Post-high school+ |
28,171 |
67.5 |
28,110 |
72.5 |
13,696 |
70.4 |
14,554 |
68.0 |
| Body mass index at baseline |
||||||||
| <25 kg/m2 |
18,461 |
44.7 |
18,855 |
48.9 |
9,040 |
46.6 |
8,718 |
40.8 |
| 25–30 kg/m2 |
13,144 |
31.8 |
12,331 |
32.0 |
6,407 |
33.0 |
7,290 |
34.2 |
| 30+ kg/m2 |
9,719 |
23.5 |
7,342 |
19.1 |
3,965 |
20.4 |
5,335 |
25.0 |
| Smoking |
||||||||
| Never |
19,321 |
46.3 |
18,123 |
47.0 |
8,996 |
46.4 |
8,984 |
42.1 |
| Former |
16,758 |
40.2 |
15,314 |
39.7 |
7,735 |
39.9 |
9,184 |
43.0 |
| Current |
5,630 |
13.5 |
5,137 |
13.3 |
2,656 |
13.7 |
3,193 |
14.9 |
| Alcoholic drinks |
||||||||
| 0 drinks per day |
14,515 |
33.8 |
9,136 |
23.0 |
4,784 |
23.9 |
7,009 |
31.7 |
| <1 drink per day |
23,322 |
54.3 |
24,771 |
62.3 |
12,299 |
61.3 |
12,111 |
54.9 |
| 1–3 drinks per day |
4,037 |
9.4 |
4,727 |
11.9 |
2,382 |
11.9 |
2,297 |
10.4 |
| 3+ drinks per day |
1,086 |
2.5 |
1,147 |
2.9 |
592 |
3.0 |
663 |
3.0 |
| Self-reported general health |
||||||||
| Excellent/very good/good |
36,189 |
85.6 |
36,638 |
93.3 |
17,869 |
90.4 |
17,868 |
82.4 |
| Fair/poor |
6,094 |
14.4 |
2,639 |
6.7 |
1,891 |
9.6 |
3,814 |
17.6 |
| Stroke |
||||||||
| No |
42,293 |
98.4 |
39,557 |
99.4 |
19,844 |
98.9 |
21,112 |
95.6 |
| Yes |
667 |
1.6 |
224 |
0.6 |
213 |
1.1 |
968 |
4.4 |
| Heart disease |
||||||||
| No |
39,820 |
92.7 |
38,292 |
96.3 |
18,924 |
94.4 |
17,561 |
79.5 |
| Yes |
3,140 |
7.3 |
1,489 |
3.7 |
1,133 |
5.6 |
4,519 |
20.5 |
| High blood pressure |
||||||||
| No |
24,240 |
60.2 |
25,179 |
67.7 |
11,484 |
61.5 |
9,502 |
46.1 |
| Yes |
16,001 |
39.8 |
11,997 |
32.3 |
7,192 |
38.5 |
11,117 |
53.9 |
| Mammogram in past 3 years |
||||||||
| Once or less |
13,226 |
31.0 |
12,161 |
30.8 |
6,043 |
30.4 |
6,496 |
29.8 |
| Yes, more than once |
29,408 |
69.0 |
27,298 |
69.2 |
13,827 |
69.6 |
15,327 |
70.2 |
| Age at menarche |
||||||||
| <13 years |
21,222 |
49.8 |
18,850 |
47.8 |
9,679 |
48.7 |
11,036 |
50.4 |
| 13–14 years |
17,452 |
41.0 |
17,101 |
43.4 |
8,407 |
42.3 |
8,859 |
40.5 |
| 15+ years |
3,909 |
9.2 |
3,492 |
8.9 |
1,792 |
9.0 |
1,981 |
9.1 |
| Parity |
||||||||
| Nulliparous |
6,253 |
14.8 |
5,996 |
15.3 |
2,808 |
14.2 |
3,089 |
14.3 |
| One |
4,459 |
10.6 |
4,056 |
10.4 |
2,009 |
10.2 |
2,172 |
10.0 |
| Two |
11,052 |
26.2 |
10,488 |
26.8 |
5,290 |
26.8 |
5,406 |
25.0 |
| Three or more |
20,431 |
48.4 |
18,578 |
47.5 |
9,608 |
48.7 |
10,987 |
50.7 |
| Age at first live birth |
||||||||
| Nulliparous |
6,253 |
14.8 |
5,996 |
15.3 |
2,808 |
14.2 |
3,089 |
14.2 |
| <20 years |
7,385 |
17.4 |
6,016 |
15.3 |
3,319 |
16.8 |
3,895 |
17.9 |
| 20–24 years |
18,472 |
43.6 |
17,112 |
43.6 |
8,861 |
44.9 |
9,800 |
45.1 |
| 25–29 years |
7,636 |
18.0 |
7,582 |
19.3 |
3,632 |
18.4 |
3,739 |
17.2 |
| 30+ years |
2,575 |
6.1 |
2,499 |
6.4 |
1,129 |
5.7 |
1,191 |
5.5 |
| Age at menopause |
||||||||
| Premenopausal |
1,462 |
3.4 |
1,738 |
4.4 |
742 |
3.7 |
445 |
2.0 |
| <45 years |
2,834 |
6.6 |
2,429 |
6.1 |
1,266 |
6.3 |
1,593 |
7.2 |
| 45–49 years |
6,543 |
15.2 |
6,316 |
15.9 |
2,997 |
14.9 |
3,358 |
15.2 |
| 50–54 years |
11,362 |
26.4 |
11,870 |
29.8 |
5,415 |
27.0 |
5,732 |
26.0 |
| 55+ years |
2,650 |
6.2 |
2,555 |
6.4 |
1,218 |
6.1 |
1,284 |
5.8 |
| Surgical menopause |
16,770 |
39.0 |
13,577 |
34.1 |
7,754 |
38.7 |
8,975 |
40.6 |
| Postmenopausal, age unknown |
1,339 |
3.1 |
1,296 |
3.3 |
665 |
3.3 |
693 |
3.1 |
| Hormone therapy formulation |
||||||||
| Never used |
17,328 |
42.4 |
15,676 |
41.2 |
7,201 |
37.6 |
8,371 |
39.8 |
| Estrogen therapy only |
11,901 |
29.1 |
10,157 |
26.7 |
5,844 |
30.5 |
6,724 |
32.0 |
| Estrogen–progestin therapy |
11,681 |
28.6 |
12,196 |
32.1 |
6,100 |
31.9 |
5,945 |
28.3 |
| Moderate/vigorous physical activity during past 10 years |
||||||||
| Never |
1,801 |
4.3 |
1,033 |
2.6 |
545 |
2.8 |
878 |
4.0 |
| Rarely |
4,911 |
11.6 |
4,012 |
10.2 |
1,986 |
10.1 |
2,539 |
11.7 |
| <1 hour/week |
4,473 |
10.6 |
4,102 |
10.5 |
2,107 |
10.7 |
2,347 |
10.8 |
| 1–3 hours/week |
10,495 |
24.9 |
10,085 |
25.7 |
5,240 |
26.6 |
5,457 |
25.1 |
| 4–7 hours/week |
10,379 |
24.6 |
10,438 |
26.6 |
5,311 |
26.9 |
5,371 |
24.7 |
| >7 hours/week |
10,100 |
24.0 |
9,548 |
24.3 |
4,546 |
23.0 |
5,122 |
23.6 |
| Number breast biopsies |
||||||||
| None |
32,240 |
75.8 |
30,183 |
76.6 |
14,985 |
75.4 |
16,551 |
75.8 |
| One |
6,819 |
16.0 |
6,175 |
15.7 |
3,217 |
16.2 |
3,428 |
15.7 |
| Two |
1,904 |
4.5 |
1,666 |
4.2 |
926 |
4.7 |
997 |
4.6 |
| Three or more |
1,581 |
3.7 |
1,360 |
3.5 |
737 |
3.7 |
863 |
4.0 |
| Family history of breast cancer in first degree relative (male or female) |
||||||||
| No |
29,536 |
83.5 |
27,782 |
83.8 |
13,814 |
83.6 |
14,930 |
83.4 |
| Yes |
5,838 |
16.5 |
5,356 |
16.2 |
2,708 |
16.4 |
2,978 |
16.6 |
|
aMissing values were excluded from percentage calculations. | ||||||||
Gierach et al. Breast Cancer Research 2008 10:R38 doi:10.1186/bcr2089 |
||||||||